Dispensing device, storage device and method for dispensing a formulation

Information

  • Patent Grant
  • 10124129
  • Patent Number
    10,124,129
  • Date Filed
    Wednesday, December 24, 2008
    15 years ago
  • Date Issued
    Tuesday, November 13, 2018
    5 years ago
Abstract
The invention relates to a dispensing device, a storage device and a method for dispensing a medical formulation. Multiple doses of the formulation are stored in a carrier having multiple storage members, each storage member containing a single dose. Each storage member comprises one duct or nozzle for dispensing the respective dose. The dispensing direction of the ducts or nozzles is directed in a lengthwise or indexing direction of the carrier. The storage device of the carrier is a peelable blister strip, wherein the ducts or nozzles can be opened one after the other by peeling the blister strip.
Description
FIELD OF THE INVENTION

The present invention relates to a dispensing device for dispensing a medical formulation, preferably dry powder inhalers for the delivery of drugs to the lungs.


BACKGROUND OF THE INVENTION

Drugs delivered through dispensing devices, in particular inhalers, are intended to optimally target specific sites in the pulmonary system. These sites include the nasal passages, the throat, and various locations within the lungs, such as the bronchi, bronchioles and alveolar regions. The ability to deliver drugs to a target area depends inter alia on the aerodynamic sizes of the particles or droplets. As currently believed to be understood, particles having an aerodynamic diameter of less than 2 μm are considered to be potentially optimal for deposition in the alveolar region of the lung. Particles that have an aerodynamic diameter of between 2 and approximately 5 μm may be more suitable for delivery to the bronchiole or bronchi regions. Particles with an aerodynamic size range greater than 6 μm, and more preferably 10 μm, are typically suitable for delivery to the laryngeal region, throat or nasal passages.


In most cases, it is desired to achieve a high inhalable fraction and a high delivery efficiency, i.e. the fraction of the initial dose of drug that reaches the desired region, in particular in the lung. This depends on various factors, in particular on the characteristics of the generated spray plume, such as propagation velocity of the plume, particle size and its distribution, fraction of small particles, fraction of gas or the like. In the present invention, the desired spray plume characteristics include preferably a small particle size, a high fraction of drug particles with a diameter of 6 μm or less, a low propagation velocity and/or a long duration of spray generation and possible inhalation.


In the following, the description will focus mainly on powder formulations. However, the same applies for liquid formulations.


Many dry powder inhalers are on the market or have been proposed. There are two main types, namely the passive ones and the active ones. In passive inhalers all the energy required for de-agglomerating the powder and transferring the powder to the lungs is provided by the breathing of a user, respectively the patient. In active inhalers there is an additional source of energy to help to de-agglomerate the powder.


Most powder inhalers are of the passive type where the powder is inhaled by the patient without the aid of an additional energy source. The problem with passive inhalers is that the inhalable fraction, or the proportion of powder that actually enters the lungs, is largely dependent on the breathing of the patient. The de-agglomeration of the powder and hence the inhalable fraction is a function of the flow rate of inhaled air through the device and, therefore, varies greatly from patient to patient.


Dry powder inhalers are subdivided into single dose and multi-dose devices or inhalers. Multi-dose inhalers are further subdivided into pre-metered types where the doses are stored individually and into metering inhalers where each powder dose is metered in the device.


Multi dose pre-metered inhalers have the advantage that the single doses are metered under strict factory conditions and the powder can quite easily be isolated from the atmosphere. In many applications the active drug powder is mixed with a carrier such as lactose which tends to absorb humidity from the atmosphere which makes it stick together and difficult to de-agglomerate.


U.S. Pat. No. 4,627,432 A discloses a device for administering medicaments to patients, namely an inhaler. The inhaler comprises a disk-like blister pack having a plurality of blister pockets arranged in a circle. Each blister pocket contains a dose of the powder. A plunger can open a blister pocket. When a blister is opened, the medicament can be withdrawn by a patient inhaling through a mouthpiece.


It is difficult to empty the respective blister pocket completely during a dispensing operation. Incomplete emptying results in decreased delivery efficiency. Some powder may be lost in the inhaler and not dispensed because the known solutions require relatively long paths for the powder until the powder reaches a nozzle and is actually dispensed. This might reduce the delivery efficiency further. In addition, de-agglomeration of the powder is difficult and the powder may block an outlet nozzle that is used for dispensing multiple doses one after the other.


WO 2007/062721 A1, which forms the starting point of the present invention, discloses a dispensing device for dispensing a preferably medical formulation as a spray. The dispensing device is adapted to receive or comprises a storage device. The storage device comprises a carrier with multiple cavities. Each cavity comprises a moveable insert. Each insert comprises a storage chamber with a dose of the formulation, and a duct for dispensing the respective dose. The cavities are sealed. The sealings can be opened by pushing the respective insert through the associated sealing. Then, the respective dose is dispensed by pressurized air supplied to the insert.


Object of the present invention is to provide an improved dispensing device, storage device and method for dispensing a preferably medical formulation, in particular wherein a very simple design of the storage device and/or simple opening of the storage device can be achieved.


The above object is achieved by a dispensing device, by a storage device or by a method as disclosed and described herein.


SUMMARY OF THE INVENTION

As noted above, the present invention relates to a dispensing device for dispensing a medical formulation, preferable dry powder inhalers for the delivery of drugs to the lungs. In particular, the present invention relates to an active, gas (preferably air) powered, pre-metered multi-dose dispensing device for dispensing a formulation containing or consisting of a drug, such as a dry powder inhaler.


In one embodiment, the invention relates to a dispensing device (1) for dispensing a preferably medical formulation (2) (“the dispensing device of the invention”), in particular containing or consisting of a drug, as a spray (3), wherein the dispensing device (1) is adapted to receive or comprises a storage device (4), the storage device (4) comprising a carrier (5) with multiple storage members (6), each storage member (6) comprising a storage cavity (9) containing a dose of the formulation (2), and a duct (10) or nozzle (11) for dispensing the respective dose in a dispensing direction (12).


In another embodiment, the invention relates to a device as described in the embodiment immediately above, characterized in that the formulation (2) is a liquid, in particular a solution, suspension or solution.


In another embodiment, the invention relates to a device as described in the embodiment immediately above, characterized in that the formulation (2) is a powder.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the carrier (5) is flexible and/or band-like and/or is a blister, preferably a blister strip.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the carrier (5) comprises the base layer (7) and the peelable cover layer (8), wherein the storage members (6) are inserted or held between these layers (7, 8) before and/or during dispensing.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the storage members (6) are parts made separately from the carrier (5).


In another embodiment, the invention relates to a device as described in any of the first four embodiments above, characterized in that the storage members (6) are formed by the carrier (5), in particular the base layer (7) and the cover layer (8) of the carrier (5).


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that each storage member (6) is a molded element, a cartridge, a capsule or a container.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that each storage member (6) is rigid or flexible.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the dispensing device (1) comprises an opening, connecting and/or supply means (14), in particular a piercing element (15), such as a needle, for opening or piercing the storage members (6) individually and/or supplying pressurized gas to the respective storage member (6) to dispense the respective dose.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the dispensing device (1) comprises means for providing pressurized gas, in particular air, for dispensing the formulation (2), preferably wherein the dispensing device (1) comprises a preferably manually operated air pump (13) as means for providing pressurized gas.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the dispensing device (1) is designed such that the carrier (5) can be moved or indexed stepwise from one storage member (6) to the next storage member (6).


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the dispensing device (1) is a preferably oral inhaler, in particular a dry powder inhaler.


In another embodiment, the invention relates to a device as described in any of the above embodiments, characterized in that the storage members (6), ducts (10) or nozzles (11) are sealed by one common sealing or cover layer (8).


In another embodiment, the invention relates to a storage device (4) for a preferably medical formulation (2) (“the storage device of the invention”), in particular containing or consisting of a drug, preferably for a dispensing device (1) as described in any of the embodiments above, the storage device (4) comprising a carrier (5) with multiple storage members (6), each storage member (6) comprising a storage cavity (9) containing a dose of the formulation (2), and a duct (10) or nozzle (11) for dispensing the respective dose in a dispensing direction (12),


characterized in


that the dispensing direction (12) of the ducts (10) or nozzles (11) is directed in a lengthwise direction of the storage device (4) or carrier (5), and/or


that the storage device (4) or carrier (5) is a peelable blister strip, wherein the ducts (10) or nozzles (11) can be opened one after the other by peeling the blister strip, and/or


that the carrier (5) carries the storage members (6) formed separately from the carrier (5) rigidly or in a unmovable manner and is adapted that the storage members (6), the ducts (10) or the nozzles (11) can be opened without movement of the storage members (6) or a base layer (7) thereof by opening or peeling a preferably common feeling or cover layer (8).


In another embodiment, the invention relates to storage device of the invention, characterized in that the formulation (2) is a liquid, in particular a solution, suspension or suslution.


In another embodiment, the invention relates to storage device of the invention, characterized in that the formulation (2) is a powder.


In another embodiment, the invention relates to storage device of the invention as described in the three embodiments immediately above, characterized in that the carrier (5) is flexible and/or band-like.


In another embodiment, the invention relates to storage device of the invention as described in the four embodiments immediately above, characterized in that the carrier (5) comprises a base layer (7) and a peelable cover layer (8), wherein the storage members (6) are inserted or held between these layers (7, 8) before and/or during dispensing.


In another embodiment, the invention relates to storage device of the invention as described in the five embodiments immediately above, characterized in that the storage members (6) are parts made separately from the carrier (5).


In another embodiment, the invention relates to storage device of the invention as described in the first four storage device embodiments above, characterized in that the storage members (6) are formed by the carrier (5), in particular a base layer (7) and a cover layer (8) of the carrier (5).


In another embodiment, the invention relates to storage device of the invention as described in the seven embodiments immediately above, characterized in that each storage member (6) is a molded element, a cartridge, a capsule or a container.


In another embodiment, the invention relates to storage device of the invention as described in the eight embodiments immediately above, characterized in that each storage member (6) is rigid or flexible.


In another embodiment, the invention relates to storage device of the invention as described in the five embodiments immediately above, characterized in that the storage members (6), ducts (10) or nozzles (11) are sealed by one common sealing or cover layer (8).


In another embodiment, the invention relates to a method for dispensing a preferably medical formulation (2) (“the dispensing method of the invention”), in particular containing or consisting of a drug, as a spray (3) from a blister strip comprising with multiple storage members (6), each storage member (6) comprising a storage cavity (9) containing a dose of the formulation (2), and a duct (10) or nozzle (11) for dispensing the respective dose,


characterized in


that the blister strip is peeled to open the storage members (6), the ducts (10) or the nozzles (11) one after the other so that the doses can be dispensed one after the other.


In another embodiment, the invention relates to storage device of the invention as described in the embodiment immediately above, characterized in that the storage members (6), ducts (10) or nozzles (11) are sealed by one common sealing or cover layer (8), wherein the common sealing or cover layer (8) is peeled.


In another embodiment, the invention relates to storage device of the invention as described in the two embodiments immediately above, characterized in that the storage members (6) are individually connected to a supply of pressurized gas, in particular by piercing the respective storage member (6) by means of a piercing element (15).


In another embodiment, the invention relates to storage device of the invention as described in the three embodiments immediately above, characterized in that the doses are individually subjected to a gas pressure for dispensing.


In another embodiment, the invention relates to storage device of the invention as described in the embodiment immediately above, characterized in that air is pressurized and used as gas, in particular wherein air is pressurized by manually operating an air pump (13).


In one embodiment, the medical formulation described in any of the embodiments above contains a drug or mixture of drugs.


In another embodiment, the medical formulation described in any of the embodiments above consists of a drug or mixture of drugs.


The term “formulation” relates in particular to powder, but may include or relate to liquid as well. Consequently, the fine “particles” may be either solid or liquid. The term “liquid” has to be understood preferably in a broad sense covering inter alia solutions, suspensions, suslutions, mixtures thereof or the like. More particularly, the present invention relates to the dispensing of formulations for inhalation, such as medical formulations containing or consisting of at least one drug.


According to a first aspect of the present invention, the dispensing direction of the ducts or nozzles of storage members located on a carrier is directed at least essentially in a lengthwise or indexing direction of the storage device or carrier. This allows in particular a very simple construction and/or opening.


According to a second aspect of the present invention, the storage device or carrier is a peelable blister strip, wherein the ducts or nozzles can be opened one after the other by peeling the blister strip. This allows a very simple construction and/or opening.


According to a third aspect of the present invention, the storage members are separate parts that are fixed on the carrier and cannot be moved relatively to the carrier. The storage members or its ducts or nozzles are closed by a preferably common sealing or cover layer. The storage members, ducts or nozzles can be opened one after the other by opening or peeling the sealing or cover layer. This allows a very simple construction and/or opening.


It has to be noted that each storage member preferably comprises an individual duct or nozzle for dispensing the respective dose. In particular, a spray is directly or only to formed by or directly after the duct or nozzle. The duct or nozzle may dispense the generated spray in to a mouthpiece for inhalation by a user or patient. However, any further spray forming means is preferably not provided.





BRIEF DESCRIPTION OF THE DRAWINGS

Further aspects, advantages and features of the present invention will be apparent from the claims and following detailed description of preferred embodiments. In the drawings show:



FIG. 1 a schematic sectional view of a dispensing device with a storage device according to the present invention during dispensing;



FIG. 2 a top view of a part of the storage device with multiple storage members;



FIG. 3 a schematic sectional view of a part of the storage device with one storage member;



FIG. 4 a schematic sectional view of a part of the storage device according to an other embodiment;



FIG. 5 a schematic sectional view of a part of the storage device according to a further embodiment;



FIG. 6 a schematic sectional view of a part of the storage device according to still an other embodiment;



FIG. 7 a schematic sectional view of a part of the storage device shown in FIGS. 1 to 3 when pierced to discharge a formulation; and



FIG. 8 a sectional view perpendicular to FIG. 7.





In the Fig., the same reference signs are used for same or similar components, wherein same or similar characteristics, features or advantages are or can be realized or achieved even if a repeated discussion is omitted. Further, the features and aspects of the different embodiments can be combined in any desired manner and/or used for other dispensing devices or methods for dispensing in particular medical formulations for inhalation.


DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows in a schematic sectional view—for illustration purposes not in scale—a dispensing device 1 according to the present invention. The dispensing device 1 is an active device, in particular gas powered. Here, the dispensing device 1 is a preferably oral or nasal inhaler, in particular a dry powder inhaler, for a user, respectively the patient (not shown).


The dispensing device 1 may be used for dispensing any formulation 2 as defined in the introductory part of the description. In particular, a medical formulation 2 or a formulation 2 for inhalation will be used. The formulation 2 preferably contains or consists of at least one drug. When the formulation 2 is dispensed, a spray 3 is generated as indicated in FIG. 1. The spray 3 includes fine particles (solid and/or liquid) of the formulation 2 and preferably has the desired spray plume characteristics.


The formulation 2 may be a liquid, in particular a solution, a suspension or any mixture thereof, i.e. a so-called suslution. Preferably, when different drugs are dispensed simultaneously, a suslution may be used. The principle of the suslution is based on that different drugs may be combined in one formulation simultaneously as a solution and as a suspension. In this respect, reference is made to EP 1 087 750 A1 which is incorporated herein as additional disclosure in this respect.


Preferably, the formulation 2 is a powder. The powder may be a pure drug or a mixture of at least two drugs. In addition, the powder may contain at least one other material, in particular a drug carrier such as lactose. In the following, the description focuses on powder as formulation 2. However, the description applies in a similar manner if a liquid formulation 2 is used.


Preferably the mean diameter of the powder particles is about 2 to 7 μm, in particular 6 μm or less. This applies in particular if the powder does not contain any drug carrier such as lactose.


If the powder contains a drug carrier, such as lactose, and at least one drug, the powder 2 may have a particle size of 20 to 300 μm, in particular about 30 to 60 μm. However, the de-agglomeration, which will be described later in more detail, may result even in this case in a spray 3 with a smaller particle size, e.g. of about 10 μm or less. In particular, the drug may be separated from the drug carrier during de-agglomeration so that primarily the drug will be inhaled due to its small particle size of about 2 to 6 μm and the larger drug carrier will be swallowed when using the dispensing device as an inhaler. Alternatively or additionally, breaking or opening of the drug carrier is possible during de-agglomeration.


The diameters mentioned above and below may be understood as mass medium aerodynamic diameters and/or may apply to the particle size or a fraction of the particles of the spray 3.


The dispensing device 1 is adapted to receive or comprises a storage device 4 for storing preferably multiple and pre-metered doses of the formulation 2. The storage device 4 may be integrated into the dispensing device 1 or form part of the dispensing device 1. Alternatively, the storage device 4 may be a separate part that can be inserted or connected with the dispensing device 1 and optionally replaced.


The storage device 4 comprises a carrier 5 with storage members 6, as shown also in the top view of FIG. 2 of a part of the storage device 4. In particular, the carrier 5 may comprise 20 to 100, preferably 30 to 60 storage members 6. Each storage member 6 contains preferably one pre-metered dose of the formulation 2. However, each storage member 6 may also contain more than one formulation 2, i.e. different formulations 2. Additionally or alternatively, different storage members 6 may contain different formulations 2. In the present invention, “different” means in particular that the formulations 2 differ in at least one of the composition, the drug, the dose or amount, the concentration, and consistence of the formulation 2, e.g. liquid or dry or powder.


The storage device 4 or carrier 5 is preferably a blister strip.


In the present embodiment, the carrier 5 comprises a base layer 7 and a sealing or cover layer 8, as shown in FIG. 3 representing a schematic sectional, longitudinal view of a part of the storage device 4 with one storage member 6.


In the present embodiment, the storage members 6 are preferably formed or made as separate parts. In particular, the storage members 6 are mounted or fixed on the carrier 5 or inserted or held between the two layers 7 and 8 before and/or during dispensing.


Before use or opening, the storage members 6 are sealed by the base layer 7 and/or cover layer 8. In the present embodiment, the base layer 7 is indented and/or follows the contour of the preferably bulky storage members 6. The storage members 6 preferably end at least essentially flat in the main plane of the base layer 7. The cover layer 8 is preferably flat and forms a sealing or cover so that the storage members 6 are sealed from each other and/or hermetically against the atmosphere.


The base layer 7 may be formed by any suitable material, in particular plastic or the like, most preferably by any suitable composite material.


The cover layer 8 may be formed by any suitable material, in particular aluminum foil, a composite foil or any other suitable material.


However, other constructions are possible. In particular, the base layer 7 may be flat and the cover layer 8 may be indented. Alternatively, both layers 7 and 8 may be indented and/or non-flat.


Alternatively or additionally, the layers 7 and 8 and/or other parts of the carrier 5 may form the storage members 6.


The storage device 4, carrier 5 or blister strip is preferably longitudinal and/or band-like.


In particular, the storage members 6 are located one after the other in a row and spaced in lengthwise or longitudinal direction of the storage device 4, carrier 5 or blister strip.


Preferably, each storage member 6 is made of foil, plastics, ceramics and/or composite material, in particular of thermoplastics or thermoplastic elastomers and for sealings of elastomers or silicone.


Each storage member 6 may form a preferably block-like unit and be rigid. Alternatively, the storage members 6 may be flexible. In particular, each storage member 6 may be a unitary unit or consists of multiple elements. Each storage member 6 may be a molded element, a cartridge, a blister, a capsule, a container or the like.


In the following, a preferred construction of one storage member 6 is explained. Preferably, all storage members 6 are identical. However, it is also possible that all or some storage members 6 are different. For example, two or more groups of different storage members 6 can be provided. It is possible that one group has a different dose or different formulation 2 than the other group. For example, the storage members 6 of the different groups could be arranged alternately one after the other so that a patient or user may use for example each morning a storage member 6 of one group and each evening a storage member 6 of the other group.


Each storage member 6 comprises a storage chamber 9 for the formulation 2.


Each storage member 6 further comprises a duct 10 or the like for discharging the formulation 2 during the dispensing operation. The formulation 2 is dispensed through the duct 10 during the dispensing operation, in particular for de-agglomerating the powder and/or forming the spray 3.


The duct 10 can comprise or form a nozzle 11 preferably at the outlet. Alternatively, the nozzle 11 or any other suitable nozzle arrangement could be used instead of or in any other combination with duct 10.


Preferably, the duct 10/nozzle 11 is formed integrally with the storage chamber 9 and/or by a base member of the storage member 6, in particular by a recess, grove or the like in the base member 11, and by an associated cover member of the storage member 6. In particular, the duct 10 forms a channel from the storage chamber 9 to an outlet of the storage member 6 for discharging the formulation 2 as spray 3 as shown in FIG. 1.


Preferably, the duct 10/nozzle 11 dispenses the dose of formulation 2 of the respective storage member 6 in a dispensing direction as indicated by arrow 12 in FIG. 1.


Preferably, the dispensing direction 12, the duct 10 and/or the nozzles 11 are directed in a lengthwise or indexing direction of the storage device 4/carrier 5/blister strip. This allows a very simple and compact design of the dispensing device 1 and/or storage device 4.


Preferably, the storage members 6/ducts 10/nozzles 11 are opened one after the other—i.e. individually—by peeling the blister strip, in particular the cover layer 8 and/or base layer 7, so that the respective doses of the formulation 2 can be dispensed one after the other.


Preferably, the formulation 2 is dispensed by gas pressure, in particular air pressure (active inhaler). However, it is also possible to dispense the formulations 2 by means of an air stream generated by breathing in of a user or patient (not passive inhaler).


In the present embodiment, the dispensing device 1 uses pressurized gas to force the formulation 2 through the duct 10/nozzle 11 to de-agglomerate the powder and/or to generate the spray 3. Preferably, the dispensing device 1 comprises a means for providing pressurized gas, in the present embodiment an air pump 13 which can preferably be actuated or operated manually. In particular, the air pump 13 comprises or is formed by a bellows. But, it could be also a piston-cylinder-arrangement. Instead of the air pump 13, the means for providing pressurized gas can be e.g. a capsule, container or the like containing pressurized or liquefied gas for powering the dispensing device 1, i.e. dispensing the formulation 2 as desired.


The air pump 13 may provide a gas pressure of less than 300 kPa, in particular about 50 to 200 kPa. This is preferably sufficient for operating the dispensing device 1. If liquefied gas or a container with pressurized gas is used, the gas pressures might range from 100 kPa to about 700 kPa. Then, the pressure may be reduced or throttled to the preferred pressure range before supplying the gas to the storage device 4, in particular the storage chamber 9 of the respective storage member 6.


Preferably, all pressure values mentioned in the present description are gauge pressures, i.e. pressure differences. All pressure values relate to the pressure in a gas storage such as a container with pressurized or liquefied gas or provided by air pump 13 or relate to the pressures acting in the storage chamber 9 and/or in the duct 10.



FIG. 1 shows schematically that the dispensing device 1 comprises a mechanism 14 for connecting the storage members 6 individually to the gas supply, in particular to the air pump 13. The mechanism 14 comprises preferably a piercing element 15, such as a hollow needle, or any other suitable connecting element.


The connecting mechanism 14 is preferably designed such that it open 5 or pierces the storage chamber 9 of the storage members 6 that shall be emptied next. In particular, the piercing element 15 can penetrate the base layer 7 and/or cover layer 8 and the wall of the storage chamber 9 so that gas can be supplied into the storage chamber 9 to generate a gas stream which entrains the formulation 2 in the storage chamber 9 and dispenses the formulation 2 through the duct 10/nozzle 11 and generates the spray 3 as schematically shown in FIG. 1.


Actuation and/or movement of the connecting mechanism 14 and/or piercing element 15 can be combined with the actuation of the means for pressurizing gas (air pump 13) or operated separately.


Preferably the storage chamber 9 forms a mixing chamber for mixing the gas with the powder. The chamber 9 is preferably designed such that the gas can generate swirls or eddies for better mixing the powder with the gas. Preferably, the chamber 9 is substantially circular in cross section, in particular cylindrical. However, other shapes are also possible.


Further, the chamber 9 is formed with no sharp edges, corners or the like, but has a smooth contour so that the gas can sweep all chamber surfaces to prevent powder accumulating on said surfaces and to ensure or allow complete discharge of the powder. In particular, the gas inlet formed by the piercing element 15 or any other supply element is located opposite to the outlet, i.e. duct 10 and/or nozzle 11, with regard to the axial or outlet direction.


The duct 10 is preferably at least essentially tangentially connected to the storage chamber 9 in the embodiment. Preferably, the duct 10 is connected at one axial end of the preferably cylindrical chamber 9, and the gas inlet is inserted to the other axial end of the chamber 9. In particular, the gas inlet is connected also tangentially to the storage chamber 10, such that swirls are generated when entering the gas with a swirl direction supporting discharge of the mixture of gas and formulation 2 through the duct 10 which connects tangentially to the rotational direction of the swirl.


During the dispensing operation, the spray 3 is preferably directly generated by the respective storage member 6 or its duct 10/nozzle 11 and outputted into a mouthpiece 16 of the dispensing device 1 as shown in FIG. 1 for inhalation by a patient or user (not shown).


The powder will be discharged—in particular forced through the duct 10—with a comparatively low gas pressure (preferably less than 300 kPa, in particular about 50 to 200 kPa). This low gas pressure which is significantly lower than the gas pressures in the prior dispensing devices enables a respectively low discharge velocity and, therefore, a low spray 3 with slow propagation velocity.


After dispensing one dose or for dispensing the next dose, the piercing element 15 will be withdrawn from the connected storage member 6. During this opposite movement or by a separate actuation or during the movement for connecting the next storage member 6 to the gas supply, the carrier 5 will be indexed one step further to the next storage member 6.


In the shown embodiment, the carrier 5, base layer 7 and/or cover layer 8 may be used to feed or index or move the storage device 4 from one storage member 6 to the next storage member 6.


In particular, the base layer 7 and/or cover layer 8 can be peeled or pulled, preferably in at least essentially opposite directions or in directions inclined to each other. The storage device 4/carrier 5 and/or layers 7 or 8 may be guided by guide rollers 17 or any other suitable guiding elements and/or wound up by suitable mechanisms, in particular spooling devices 18 or the like.


Preferably, the pooling of the carrier 5 and/or of the base layer 7 and/or cover layer 8 is preferably the only drive to index the storage device 4 one step further or to the next storage member 6. However, other constructional solutions are possible as well.


The unused storage device 4 may be wound up in the dispensing device 1, e.g. together with the carrier 5, in particular base layer 7.


According to another (not shown) embodiment, the duct 10 can also be used as a reservoir (storage chamber 9) for the formulation 2. In this case, the separate storage chamber 9 is not required. Then, the duct 10 is designed to enable sufficient mixing of the gas with the formulation 2 and sufficient de-agglomeration of the powder formulation 2.


Preferably, the spray 3 has a mean velocity (taken 20 cm from the outlet 15 or mouthpiece 16) of less than 2 m/s, in particular less than 1 m/s. Preferably, the mean duration of the spray 3 is at least 0.2 or 0.3 s, in particular about 0.5 to 2 s.


According to another embodiment, a secondary packaging may be used for packing and protecting the storage device 4/carrier 5, in particular for storage purposes before storage membering the storage device 4/carrier 5 into the dispensing device 1. Additionally the whole device 1 including storage device 4/carrier 5 may be stored in a secondary water vapor proof packaging.


According to a further embodiment, the dispensing devise 1 may be breath activated, in particular wherein the formulation 2 is only released after the patient's or user's inhalation rate has reached a predetermined level, preferably by the use of a pressure sensitive means, such as a bursting element, membrane or valve, or any other mechanism.


LIST OF REFERENCE NUMBERS




  • 1 dispensing device


  • 2 formulation


  • 3 spray


  • 4 storage device


  • 5 carrier


  • 6 storage member


  • 7 base layer


  • 8 cover layer


  • 9 storage chamber


  • 10 duct


  • 11 nozzle


  • 12 dispensing direction


  • 13 air pump


  • 14 connecting mechanism


  • 15 piercing element


  • 16 mouthpiece


  • 17 guide roller


  • 18 spooling device


Claims
  • 1. A dry powder inhaler (1) for dispensing a medical powder formulation (2) containing a drug, as a powder spray (3), wherein the medical powder formulation (2) contains a drug, and wherein the dry powder inhaler (1) comprises: a storage device (4) including a carrier (5) having multiple storage members (6) in a flexible, band-like arrangement, wherein each of said multiple storage members (6) includes: (i) a respective storage cavity (9) containing a dose of the medical powder formulation (2), and (ii) a respective nozzle (11) having an outlet oriented such that the medical powder dose is dispensed from the respective storage cavity (9), through the respective nozzle, and outward from the outlet in a dispensing direction (12),characterized in that the respective nozzle (11) includes a duct (10) that forms a channel from the storage cavity (9) to the outlet, where the duct (10) is formed integrally with the storage cavity (9), and the dispensing direction (12) of the respective nozzle (11) is directed at least in a lengthwise or indexing direction of the carrier (5).
  • 2. The dry powder inhaler according to claim 1, characterized in that the carrier (5) is a blister strip.
  • 3. The dry powder inhaler according to claim 1, characterized in that the carrier (5) comprises a base layer (7) and a peelable cover layer (8), wherein the multiple storage members (6) are inserted or held between these layers (7, 8) before and/or during dispensing.
  • 4. The dry powder inhaler according to claim 1, characterized in that the multiple storage members (6) are parts made separately from the carrier (5).
  • 5. The dry powder inhaler according to claim 1, characterized in that the multiple storage members (6) are formed by the carrier (5), a base layer (7) and a cover layer (8) of the carrier (5).
  • 6. The dry powder inhaler according to claim 1, characterized in that each of the multiple storage members (6) is a molded element, a cartridge, a capsule or a container.
  • 7. The dry powder inhaler according to claim 1, characterized in that each of the multiple storage members (6) is rigid or flexible.
  • 8. The dry powder inhaler according to claim 1, characterized in that the dry powder inhaler (1) further comprises an opening, connecting and/or supply means (14), a piercing element (15) for opening or piercing the multiple storage members (6) individually and/or supplying pressurized gas to each of the multiple storage members (6) to dispense the dose from each of said multiple storage members (6).
  • 9. The dry powder inhaler according to claim 1, characterized in that the dry powder inhaler (1) further comprises a means for providing pressurized gas for dispensing the medical powder formulation (2), wherein the dry powder inhaler (1) comprises a manually operated air pump (13) as means for providing pressurized gas.
  • 10. The dry powder inhaler according to claim 1, characterized in that the dry powder inhaler (1) is designed such that the carrier (5) is capable of being moved or indexed stepwise from one of said multiple storage members (6) to the next one of said multiple storage members (6).
  • 11. The dry powder inhaler according to claim 1, characterized in that the multiple storage members (6) or nozzles (11) are sealed by one common sealing or cover layer (8).
  • 12. The dry powder inhaler of claim 1, wherein the storage device (4) or carrier (5) is a peelable blister strip, wherein the nozzle (11) is capable of being opened one after the other by peeling the blister strip.
  • 13. The dry powder inhaler of claim 1, wherein the carrier (5) carries the storage members (6) formed separately from the carrier (5) rigidly or in a unmovable manner and is adapted that each of the storage members (6) or the nozzle (11) is capable of being opened without movement of the storage members (6) or a base layer (7) thereof by opening or peeling a common sealing or cover layer (8).
  • 14. The dry powder inhaler of claim 1, further comprising a mouthpiece including a longitudinal body having an inlet end and an outlet end, the inlet end being in fluid communication with the outlet of the respective nozzle (11), and the outlet end for delivering the dose of the medical powder formulation (2) to a user, wherein the outlet of the nozzle (11), the inlet end of the longitudinal body, and the outlet end of the longitudinal body are oriented along the dispensing direction (12).
  • 15. The dry powder inhaler of claim 1, wherein the duct (10) is always open and remains open even prior to dispensing of the powder formulation.
  • 16. A storage device (4) for a medical powder formulation (2) containing a drug, for a dry powder inhaler (1), the storage device (4) comprising: a carrier (5) having multiple storage members (6) in a flexible, band-like arrangement, wherein each of said multiple storage members (6) includes: (i) a respective storage cavity (9) containing a dose of the medical powder formulation (2), and (ii) a respective nozzle (11) having an outlet oriented such that the respective medical powder formulation dose (2) is dispensed from the respective storage cavity (9), through the respective nozzle, and outward from the outlet in a dispensing direction (12),characterized in that the respective nozzle (11) includes a duct (10) that forms a channel from the storage cavity (9) to the outlet, where the duct (10) is formed integrally with the storage cavity (9), and the dispensing direction (12) of the respective nozzle (11) is directed in a lengthwise direction of the carrier (5).
  • 17. A method, comprising: dispensing a medical powder formulation (2) containing a drug, as a dry powder spray (3) from a blister strip comprising multiple storage members (6), wherein each of said multiple storage members (6) includes (i) a respective storage cavity (9) containing a dose of the medical powder formulation (2), and (ii) a respective nozzle (11) having an outlet oriented such that the medical powder formulation dose (2) is dispensed from the respective storage cavity (9), through the respective nozzle, and outward from the outlet in a dispensing direction (12), wherein the respective nozzle (11) includes a duct (10) that forms a channel from the storage cavity (9) to the outlet, where the duct (10) is formed integrally with the storage cavity (9), and the dispensing direction (12) of the respective nozzle (11) is directed in a lengthwise direction of the carrier (5), andpeeling the blister strip to open each of the multiple storage members (6) and expose the respective nozzle (11), one after the other, so that the medical powder formulation dose (2) in each of said multiple storage members (6) is dispensed one after the other.
  • 18. Method according to claim 17, characterized in that each of the storage members (6) or nozzle (11) is sealed by one common sealing or cover layer (8), wherein the common sealing or cover layer (8) is peeled.
  • 19. Method according to claim 17, characterized in that the storage members (6) are individually connected to a supply of pressurized gas by piercing each of the respective storage members (6) by means of a piercing element (15).
Priority Claims (1)
Number Date Country Kind
08000010 Jan 2008 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2008/011112 12/24/2008 WO 00 7/30/2010
Publishing Document Publishing Date Country Kind
WO2009/083244 7/9/2009 WO A
US Referenced Citations (522)
Number Name Date Kind
1828864 Hopkins Oct 1931 A
2015970 Schoene Oct 1935 A
2127401 Gillican Aug 1938 A
2161071 McGrath et al. Jun 1939 A
2321428 Schloz Jun 1943 A
2329311 Waters Sep 1943 A
2362103 Smith Nov 1944 A
2651303 Johnson et al. Sep 1953 A
2720969 Kendall Oct 1955 A
2793776 Lipari May 1957 A
2974880 Stewart et al. Mar 1961 A
3032823 Sherman et al. May 1962 A
3157179 Allen et al. Nov 1964 A
3172568 Modderno Mar 1965 A
3196587 Hayward et al. Jul 1965 A
3223289 Bouet Dec 1965 A
3299603 Shaw Jan 1967 A
3348726 LaCross Oct 1967 A
3354883 Southerland Nov 1967 A
3425591 Pugh Feb 1969 A
3440144 Anderson et al. Apr 1969 A
3457694 Tatibana Jul 1969 A
3491803 Galik Jan 1970 A
3502035 Fedit Mar 1970 A
3580249 Takaoka May 1971 A
3590557 Vogel Jul 1971 A
3606106 Yuhas Sep 1971 A
3632743 Geller et al. Jan 1972 A
3655096 Easter Apr 1972 A
3674060 Ruekberg Jul 1972 A
3675825 Morane Jul 1972 A
3684124 Song Aug 1972 A
3802604 Morane et al. Apr 1974 A
3817416 Costa Jun 1974 A
3820698 Franz Jun 1974 A
3842836 Ogle Oct 1974 A
3858580 Ogle Jan 1975 A
3861851 Schiemann Jan 1975 A
3870147 Orth Mar 1975 A
3924741 Kachur et al. Dec 1975 A
3933279 Maier Jan 1976 A
3946732 Hurscham Mar 1976 A
3949751 Birch et al. Apr 1976 A
3951310 Steiman Apr 1976 A
3953995 Haswell et al. May 1976 A
3973603 Franz Aug 1976 A
4012472 Lindsey Mar 1977 A
4031892 Hurschman Jun 1977 A
4036439 Green Jul 1977 A
4048997 Raghavachari et al. Sep 1977 A
4067499 Cohen Jan 1978 A
4094317 Wasnich Jun 1978 A
4120995 Phipps et al. Oct 1978 A
4126559 Cooper Nov 1978 A
4153689 Hirai et al. May 1979 A
4174035 Wiegner Nov 1979 A
4177938 Brina Dec 1979 A
4178928 Tischlinger Dec 1979 A
4195730 Hunt Apr 1980 A
4245788 Wright Jan 1981 A
4275840 Staar Jun 1981 A
4315570 Silver et al. Feb 1982 A
4338765 Ohmori et al. Jul 1982 A
4377106 Workman et al. Mar 1983 A
4434908 French Mar 1984 A
4456016 Nowacki et al. Jun 1984 A
4463867 Nagel Aug 1984 A
4467965 Skinner Aug 1984 A
4474302 Goldberg et al. Oct 1984 A
4476116 Anik Oct 1984 A
4515586 Mendenhall et al. May 1985 A
4516967 Kopfer May 1985 A
4524888 Tada Jun 1985 A
4603794 DeFord et al. Aug 1986 A
4677975 Edgar et al. Jul 1987 A
4727985 McNeirney et al. Mar 1988 A
4749082 Gardiner et al. Jun 1988 A
4796614 Nowacki et al. Jan 1989 A
4805377 Carter Feb 1989 A
4813210 Masuda et al. Mar 1989 A
4821923 Skorka Apr 1989 A
4840017 Miller et al. Jun 1989 A
4863720 Burghart et al. Sep 1989 A
4868582 Dreinhoff Sep 1989 A
4885164 Thurow Dec 1989 A
4905450 Hansen et al. Mar 1990 A
4926613 Hansen May 1990 A
4951661 Sladek Aug 1990 A
4952310 McMahan et al. Aug 1990 A
4964540 Katz Oct 1990 A
RE33441 Lemer Nov 1990 E
4973318 Holm et al. Nov 1990 A
4979941 Ogle, II Dec 1990 A
4982875 Pozzi et al. Jan 1991 A
5014492 Fiorini et al. May 1991 A
5025957 Ranalletta et al. Jun 1991 A
5059187 Sperry et al. Oct 1991 A
5060791 Zulauf Oct 1991 A
5067655 Farago et al. Nov 1991 A
5156918 Marks et al. Oct 1992 A
5174366 Nagakura et al. Dec 1992 A
5207217 Cocozza et al. May 1993 A
5230884 Evans et al. Jul 1993 A
5237797 Varlet Aug 1993 A
5246142 DiPalma et al. Sep 1993 A
5261565 Drobish et al. Nov 1993 A
5263842 Fealey Nov 1993 A
5271153 Reiboldt et al. Dec 1993 A
5282304 Reiboldt et al. Feb 1994 A
5282549 Scholz et al. Feb 1994 A
5284133 Burns et al. Feb 1994 A
5289948 Moss et al. Mar 1994 A
5339990 Wilder Aug 1994 A
5352196 Haber et al. Oct 1994 A
5380281 Tomellini et al. Jan 1995 A
5385140 Smith Jan 1995 A
5394866 Ritson et al. Mar 1995 A
5408994 Wass et al. Apr 1995 A
5433343 Meshberg Jul 1995 A
5435282 Haber et al. Jul 1995 A
5435884 Simmons et al. Jul 1995 A
5451569 Wong et al. Sep 1995 A
5456522 Beach Oct 1995 A
5456533 Streiff et al. Oct 1995 A
5472143 Bartels et al. Dec 1995 A
5482030 Klein Jan 1996 A
5487378 Robertson et al. Jan 1996 A
5497944 Weston et al. Mar 1996 A
5499750 Manifold Mar 1996 A
5499751 Meyer Mar 1996 A
5503869 Van Oort Apr 1996 A
5509404 Lloyd et al. Apr 1996 A
5518147 Peterson et al. May 1996 A
5533994 Meyer Jul 1996 A
5541569 Jang Jul 1996 A
5544646 Lloyd et al. Aug 1996 A
5547094 Bartels et al. Aug 1996 A
5569191 Meyer Oct 1996 A
5574006 Yanagawa Nov 1996 A
5579760 Kohler Dec 1996 A
5584285 Salter et al. Dec 1996 A
5593069 Jinks Jan 1997 A
5599297 Chin et al. Feb 1997 A
5603943 Yanagawa Feb 1997 A
5614172 Geimer Mar 1997 A
5622162 Johansson et al. Apr 1997 A
5622163 Jewett et al. Apr 1997 A
5643868 Weiner et al. Jul 1997 A
5662098 Yoshida Sep 1997 A
5662271 Weston et al. Sep 1997 A
5676930 Jager et al. Oct 1997 A
5685846 Michaels, Jr. Nov 1997 A
5697242 Halasz et al. Dec 1997 A
5709202 Lloyd et al. Jan 1998 A
5722598 Werding Mar 1998 A
5738087 King Apr 1998 A
5740967 Simmons et al. Apr 1998 A
5763396 Weiner et al. Jun 1998 A
5775321 Alband Jul 1998 A
5782345 Guasch et al. Jul 1998 A
5827262 Neftel et al. Oct 1998 A
5829435 Rubsamen et al. Nov 1998 A
5833088 Kladders et al. Nov 1998 A
5848588 Foley et al. Dec 1998 A
5868287 Kurokawa et al. Feb 1999 A
5881718 Mortensen et al. Mar 1999 A
5884620 Gonda et al. Mar 1999 A
5902298 Niedospial, Jr. et al. May 1999 A
5934272 Lloyd et al. Aug 1999 A
5935101 Kato et al. Aug 1999 A
5941244 Yamazaki et al. Aug 1999 A
5950016 Tanaka Sep 1999 A
5950403 Yamaguchi et al. Sep 1999 A
5951882 Simmons et al. Sep 1999 A
5964416 Jaeger et al. Oct 1999 A
5975370 Durliat Nov 1999 A
5997263 Van Lintel et al. Dec 1999 A
6041777 Faithfull et al. Mar 2000 A
6041969 Parise Mar 2000 A
6053368 Geimer Apr 2000 A
6062430 Fuchs May 2000 A
6098618 Jennings et al. Aug 2000 A
6109479 Ruckdeschel Aug 2000 A
6110247 Birmingham et al. Aug 2000 A
6116233 Denyer et al. Sep 2000 A
6119853 Garrill et al. Sep 2000 A
6120492 Finch et al. Sep 2000 A
6123068 Lloyd et al. Sep 2000 A
6131566 Ashurst et al. Oct 2000 A
6145703 Opperman Nov 2000 A
6149054 Cirrillo et al. Nov 2000 A
6152296 Shih Nov 2000 A
6171972 Mehregany et al. Jan 2001 B1
6176442 Eicher et al. Jan 2001 B1
6179118 Garrill et al. Jan 2001 B1
6186409 Srinath et al. Feb 2001 B1
6199766 Fox et al. Mar 2001 B1
6223933 Hochrainer et al. May 2001 B1
6224568 Morimoto et al. May 2001 B1
6237589 Denyer et al. May 2001 B1
6259654 de la Huerga Jul 2001 B1
6267154 Felicelli et al. Jul 2001 B1
6279786 de Pous et al. Aug 2001 B1
6302101 Py Oct 2001 B1
6315173 Di Giovanni et al. Nov 2001 B1
6319943 Joshi et al. Nov 2001 B1
6336453 Scarrott et al. Jan 2002 B1
6341718 Schilthuizen et al. Jan 2002 B1
6349856 Chastel Feb 2002 B1
6352152 Anderson et al. Mar 2002 B1
6352181 Eberhard et al. Mar 2002 B1
6363932 Forchione et al. Apr 2002 B1
6375048 van der Meer et al. Apr 2002 B1
6392962 Wyatt May 2002 B1
6395331 Yan et al. May 2002 B1
6401710 Scheuch et al. Jun 2002 B1
6401987 Oechsel et al. Jun 2002 B1
6402055 Jaeger et al. Jun 2002 B1
6405872 Ruther et al. Jun 2002 B1
6412659 Kneer Jul 2002 B1
6419167 Fuchs Jul 2002 B1
6423298 McNamara et al. Jul 2002 B2
6427682 Klimowicz et al. Aug 2002 B1
6446054 Mayorga Sep 2002 B1
6457658 Srinath et al. Oct 2002 B2
6464108 Corba Oct 2002 B2
6481435 Hochrainer et al. Nov 2002 B2
6491897 Freund et al. Dec 2002 B1
6503362 Bartels et al. Jan 2003 B1
6513519 Gallem Feb 2003 B2
6543448 Smith et al. Apr 2003 B1
6548647 Dietz et al. Apr 2003 B2
6550477 Casper et al. Apr 2003 B1
6565743 Poirier et al. May 2003 B1
6578741 Ritsche et al. Jun 2003 B2
6581596 Truitt et al. Jun 2003 B1
6584976 Japuntich et al. Jul 2003 B2
6606990 Stapleton et al. Aug 2003 B2
6620438 Pairet et al. Sep 2003 B2
6626309 Jansen et al. Sep 2003 B1
6640805 Castro et al. Nov 2003 B2
6641782 Mauchan et al. Nov 2003 B1
6669176 Rock Dec 2003 B2
6679254 Rand et al. Jan 2004 B1
6685691 Freund et al. Feb 2004 B1
6698421 Attolini Mar 2004 B2
6706726 Meissner et al. Mar 2004 B2
6708846 Fuchs et al. Mar 2004 B1
6725858 Loescher Apr 2004 B2
6729328 Goldemann May 2004 B2
6732731 Tseng May 2004 B1
6745763 Webb Jun 2004 B2
6779520 Genova et al. Aug 2004 B2
6789702 O'Connor et al. Sep 2004 B2
6792945 Davies et al. Sep 2004 B2
6823862 McNaughton Nov 2004 B2
6825441 Katooka et al. Nov 2004 B2
6846413 Kadel et al. Jan 2005 B1
6866039 Wright et al. Mar 2005 B1
6889690 Crowder et al. May 2005 B2
6890517 Drechsel et al. May 2005 B2
6915901 Feinberg et al. Jul 2005 B2
6929004 Bonney et al. Aug 2005 B1
6932962 Backstrom et al. Aug 2005 B1
6942127 Raats Sep 2005 B2
6964759 Lewis et al. Nov 2005 B2
6977042 Kadel et al. Dec 2005 B2
6978916 Smith Dec 2005 B2
6986346 Hochrainer et al. Jan 2006 B2
6988496 Eicher et al. Jan 2006 B1
6994083 Foley et al. Feb 2006 B2
7040311 Hochrainer et al. May 2006 B2
7066408 Sugimoto et al. Jun 2006 B2
7090093 Hochrainer et al. Aug 2006 B2
7131441 Keller et al. Nov 2006 B1
7152760 Peabody Dec 2006 B1
7258716 Shekarriz et al. Aug 2007 B2
7314187 Hochrainer et al. Jan 2008 B2
7331340 Barney Feb 2008 B2
7341208 Peters et al. Mar 2008 B2
7380575 Stricklin Jun 2008 B2
7417051 Banholzer et al. Aug 2008 B2
7451876 Bossi et al. Nov 2008 B2
7470422 Freund et al. Dec 2008 B2
7556037 Klein Jul 2009 B2
7559597 Mori Jul 2009 B2
7571722 Wuttke et al. Aug 2009 B2
7579358 Boeck et al. Aug 2009 B2
7611694 Schmidt Nov 2009 B2
7611709 Bassarab et al. Nov 2009 B2
7621266 Kladders et al. Nov 2009 B2
7645383 Kadel et al. Jan 2010 B2
7652030 Moesgaard et al. Jan 2010 B2
7665461 Zierenberg et al. Feb 2010 B2
7681811 Geser et al. Mar 2010 B2
7686014 Boehm et al. Mar 2010 B2
7717299 Greiner-Perth May 2010 B2
7723306 Bassarab et al. May 2010 B2
7743945 Lu et al. Jun 2010 B2
7779838 Hetzer et al. Aug 2010 B2
7802568 Eicher et al. Sep 2010 B2
7819342 Spallek et al. Oct 2010 B2
7823584 Geser et al. Nov 2010 B2
7837235 Geser et al. Nov 2010 B2
7849851 Zierenberg et al. Dec 2010 B2
7896264 Eicher et al. Mar 2011 B2
7980243 Hochrainer Jul 2011 B2
7994188 Disse Aug 2011 B2
8062626 Freund et al. Nov 2011 B2
8104643 Pruvot Jan 2012 B2
8167171 Moretti May 2012 B2
8298622 Nakayama et al. Oct 2012 B2
8479725 Hausmann et al. Jul 2013 B2
8495901 Hahn et al. Jul 2013 B2
8650840 Holakovsky et al. Feb 2014 B2
8651338 Leak et al. Feb 2014 B2
8656910 Boeck et al. Feb 2014 B2
8733341 Boeck et al. May 2014 B2
8734392 Stadelhofer May 2014 B2
8944292 Moreau Feb 2015 B2
8950393 Holakovsky et al. Feb 2015 B2
8960188 Bach et al. Feb 2015 B2
8997735 Zierenberg et al. Apr 2015 B2
9027854 Moser et al. May 2015 B2
9192734 Hausmann et al. Nov 2015 B2
9238031 Schmelzer et al. Jan 2016 B2
9744313 Besseler et al. Aug 2017 B2
20010008632 Freund et al. Jul 2001 A1
20010028308 De La Huerga Oct 2001 A1
20010032643 Hochrainer et al. Oct 2001 A1
20010035182 Rubin et al. Nov 2001 A1
20020000225 Schuler et al. Jan 2002 A1
20020005195 Shick et al. Jan 2002 A1
20020007155 Freund et al. Jan 2002 A1
20020046751 MacRae et al. Apr 2002 A1
20020060255 Benoist May 2002 A1
20020074429 Hettrich et al. Jun 2002 A1
20020079285 Jansen et al. Jun 2002 A1
20020092523 Connelly Jul 2002 A1
20020111363 Drechsel et al. Aug 2002 A1
20020129812 Litherland et al. Sep 2002 A1
20020130195 Jaeger et al. Sep 2002 A1
20020137764 Drechsel et al. Sep 2002 A1
20020176788 Moutafis et al. Nov 2002 A1
20030039915 Holt et al. Feb 2003 A1
20030064032 Lamche et al. Apr 2003 A1
20030066524 Hochrainer et al. Apr 2003 A1
20030066815 Lucas Apr 2003 A1
20030080210 Jaeger et al. May 2003 A1
20030085254 Katooka et al. May 2003 A1
20030098023 Drachmann et al. May 2003 A1
20030106827 Cheu et al. Jun 2003 A1
20030145849 Drinan et al. Aug 2003 A1
20030178020 Scarrott Sep 2003 A1
20030181478 Drechsel et al. Sep 2003 A1
20030183225 Knudsen Oct 2003 A1
20030187387 Wirt et al. Oct 2003 A1
20030191151 Chaudry et al. Oct 2003 A1
20030194379 Brugger et al. Oct 2003 A1
20030196660 Haveri Oct 2003 A1
20030209238 Peters et al. Nov 2003 A1
20030226907 Geser et al. Dec 2003 A1
20030234203 Urban Dec 2003 A1
20040004138 Hettrich et al. Jan 2004 A1
20040010239 Hochrainer et al. Jan 2004 A1
20040015126 Zierenberg et al. Jan 2004 A1
20040019073 Drechsel et al. Jan 2004 A1
20040055907 Marco Mar 2004 A1
20040060476 Sirejacob Apr 2004 A1
20040069799 Gee et al. Apr 2004 A1
20040092428 Chen et al. May 2004 A1
20040094147 Schyra et al. May 2004 A1
20040134494 Papania et al. Jul 2004 A1
20040134824 Chan et al. Jul 2004 A1
20040139700 Powell et al. Jul 2004 A1
20040143235 Freund et al. Jul 2004 A1
20040164186 Kladders et al. Aug 2004 A1
20040166065 Schmidt Aug 2004 A1
20040182867 Hochrainer et al. Sep 2004 A1
20040184994 DeStefano et al. Sep 2004 A1
20040194524 Jentzsch Oct 2004 A1
20040210199 Atterbury et al. Oct 2004 A1
20040231667 Horton et al. Nov 2004 A1
20050028812 Djupesland Feb 2005 A1
20050028815 Deaton et al. Feb 2005 A1
20050028816 Fishman et al. Feb 2005 A1
20050061314 Davies et al. Mar 2005 A1
20050089478 Govind et al. Apr 2005 A1
20050098172 Anderson May 2005 A1
20050126469 Lu Jun 2005 A1
20050131357 Denton et al. Jun 2005 A1
20050158394 Staniforth et al. Jul 2005 A1
20050159441 Hochrainer et al. Jul 2005 A1
20050183718 Wuttke et al. Aug 2005 A1
20050191246 Bechtold-Peters et al. Sep 2005 A1
20050194472 Geser et al. Sep 2005 A1
20050239778 Konetzki et al. Oct 2005 A1
20050247305 Zierenberg et al. Nov 2005 A1
20050250704 Bassarab et al. Nov 2005 A1
20050250705 Bassarab et al. Nov 2005 A1
20050255119 Bassarab et al. Nov 2005 A1
20050263618 Spallek et al. Dec 2005 A1
20050268909 Bonney et al. Dec 2005 A1
20050268915 Wassenaar et al. Dec 2005 A1
20050269359 Raats Dec 2005 A1
20060002863 Schmelzer et al. Jan 2006 A1
20060016449 Eicher et al. Jan 2006 A1
20060035874 Lulla et al. Feb 2006 A1
20060037612 Herder et al. Feb 2006 A1
20060067952 Chen Mar 2006 A1
20060086828 Bougamont et al. Apr 2006 A1
20060150971 Lee et al. Jul 2006 A1
20060196500 Hochrainer et al. Sep 2006 A1
20060225734 Sagaser et al. Oct 2006 A1
20060239886 Nakayama et al. Oct 2006 A1
20060239930 Lamche et al. Oct 2006 A1
20060254579 Grychowski et al. Nov 2006 A1
20060279588 Yearworth et al. Dec 2006 A1
20060282045 Wilkinson et al. Dec 2006 A1
20060285987 Jaeger et al. Dec 2006 A1
20060289002 Hetzer et al. Dec 2006 A1
20060293293 Muller et al. Dec 2006 A1
20070062518 Geser et al. Mar 2007 A1
20070062519 Wuttke et al. Mar 2007 A1
20070062979 Dunne Mar 2007 A1
20070090205 Kunze et al. Apr 2007 A1
20070090576 Geser et al. Apr 2007 A1
20070107720 Boeck et al. May 2007 A1
20070119449 Boehm et al. May 2007 A1
20070137643 Bonney et al. Jun 2007 A1
20070163574 Rohrschneider Jul 2007 A1
20070181526 Frishman Aug 2007 A1
20070183982 Berkel et al. Aug 2007 A1
20070210121 Stadelhofer et al. Sep 2007 A1
20070221211 Sagalovich Sep 2007 A1
20070264437 Zimmermann et al. Nov 2007 A1
20070272763 Dunne Nov 2007 A1
20070298116 Bechtold-Peters et al. Dec 2007 A1
20080017192 Southby et al. Jan 2008 A1
20080029085 Lawrence et al. Feb 2008 A1
20080060640 Waldner et al. Mar 2008 A1
20080083408 Hodson et al. Apr 2008 A1
20080092885 von Schuckmann Apr 2008 A1
20080156321 Bowman et al. Jul 2008 A1
20080163869 Nobutani et al. Jul 2008 A1
20080197045 Metzger Aug 2008 A1
20080249459 Godfrey et al. Oct 2008 A1
20080264412 Meyer et al. Oct 2008 A1
20080265198 Warby Oct 2008 A1
20080283553 Cox et al. Nov 2008 A1
20080299049 Stangl Dec 2008 A1
20080308580 Gaydos et al. Dec 2008 A1
20090032427 Cheu et al. Feb 2009 A1
20090060764 Mitzlaff et al. Mar 2009 A1
20090075990 Schmidt Mar 2009 A1
20090107873 Cotton Apr 2009 A1
20090114215 Boeck et al. May 2009 A1
20090166379 Wright et al. Jul 2009 A1
20090170839 Schmidt Jul 2009 A1
20090185983 Freund et al. Jul 2009 A1
20090197841 Kreher et al. Aug 2009 A1
20090202447 Kreher et al. Aug 2009 A1
20090211576 Lehtonen et al. Aug 2009 A1
20090221626 Schmidt Sep 2009 A1
20090235924 Holakovsky et al. Sep 2009 A1
20090272664 Marshall et al. Nov 2009 A1
20090293870 Brunnberg et al. Dec 2009 A1
20090306065 Schmidt Dec 2009 A1
20090308772 Abrams Dec 2009 A1
20090314287 Spallek et al. Dec 2009 A1
20090317337 Schmidt Dec 2009 A1
20100012120 Herder et al. Jan 2010 A1
20100018524 Jinks et al. Jan 2010 A1
20100018997 Faneca Llesera Jan 2010 A1
20100044393 Moretti Feb 2010 A1
20100056559 Schmelzer et al. Mar 2010 A1
20100084531 Schuchman Apr 2010 A1
20100095957 Corbacho Apr 2010 A1
20100144784 Schmelzer et al. Jun 2010 A1
20100168710 Braithwaite Jul 2010 A1
20100237102 Margheritis Sep 2010 A1
20100242557 Spreitzer et al. Sep 2010 A1
20100242954 Hahn et al. Sep 2010 A1
20100313884 Elliman Dec 2010 A1
20100331765 Sullivan et al. Dec 2010 A1
20110005517 Boeck et al. Jan 2011 A1
20110041842 Bradshaw et al. Feb 2011 A1
20110168175 Dunne et al. Jul 2011 A1
20110239594 Nottingham et al. Oct 2011 A1
20110245780 Helmer et al. Oct 2011 A1
20110268668 Lamche et al. Nov 2011 A1
20110277753 Dunne et al. Nov 2011 A1
20110290239 Bach et al. Dec 2011 A1
20110290242 Bach et al. Dec 2011 A1
20110290243 Bach et al. Dec 2011 A1
20120090603 Dunne et al. Apr 2012 A1
20120132199 Kiesewetter May 2012 A1
20120138049 Wachtel Jun 2012 A1
20120138713 Schuy et al. Jun 2012 A1
20120260913 Bach et al. Oct 2012 A1
20120325204 Holakovsky et al. Dec 2012 A1
20130012908 Yeung Jan 2013 A1
20130056888 Holakovsky et al. Mar 2013 A1
20130125880 Holakovsky et al. May 2013 A1
20130125881 Holakovsky et al. May 2013 A1
20130126389 Holakovsky et al. May 2013 A1
20130206136 Herrmann et al. Aug 2013 A1
20130269687 Besseler et al. Oct 2013 A1
20140121234 Kreher et al. May 2014 A1
20140190472 Holakovsky et al. Jul 2014 A1
20140228397 Schmelzer et al. Aug 2014 A1
20140331994 Holakovsky et al. Nov 2014 A1
20150040890 Besseler et al. Feb 2015 A1
20150040893 Besseler et al. Feb 2015 A1
20150041558 Besseler et al. Feb 2015 A1
20150114387 Bach et al. Apr 2015 A1
20150122247 Besseler et al. May 2015 A1
20150258021 Kreher et al. Sep 2015 A1
20150306087 Schmelzer et al. Oct 2015 A1
20150320947 Eicher et al. Nov 2015 A1
20150320948 Eicher et al. Nov 2015 A1
20160095992 Wachtel Apr 2016 A1
Foreign Referenced Citations (313)
Number Date Country
2005201364 Jul 2006 AU
1094549 Jan 1981 CA
2233981 Apr 1997 CA
2237853 Jun 1997 CA
2251828 Oct 1997 CA
2275392 Jul 1998 CA
2297174 Feb 1999 CA
2343123 Apr 2000 CA
2434872 Aug 2002 CA
2497059 Mar 2004 CA
2497680 Mar 2004 CA
2513167 Oct 2004 CA
2557020 Sep 2005 CA
2653183 Dec 2007 CA
2653422 Dec 2007 CA
1125426 Jun 1996 CN
1849174 Oct 2006 CN
101247897 Aug 2008 CN
1653651 Jul 1971 DE
2754100 Jun 1978 DE
4117078 Nov 1992 DE
19625027 Jan 1997 DE
19615422 Nov 1997 DE
19653969 Jun 1998 DE
19902844 Nov 1999 DE
10007591 Nov 2000 DE
10104367 Aug 2002 DE
10300983 Jul 2004 DE
102004031673 Jan 2006 DE
202006017793 Jan 2007 DE
01102006025871 Dec 2007 DE
83175 Jul 1957 DK
140801 Nov 1979 DK
0018609 Nov 1980 EP
0289332 Nov 1988 EP
0289336 Nov 1988 EP
0354507 Feb 1990 EP
0364235 Apr 1990 EP
0372777 Jun 1990 EP
0386800 Sep 1990 EP
0412524 Feb 1991 EP
0505123 Sep 1992 EP
0520571 Dec 1992 EP
0622311 Nov 1994 EP
0642992 Mar 1995 EP
0679443 Nov 1995 EP
0735048 Oct 1996 EP
0811430 Mar 1997 EP
0778221 Jun 1997 EP
0845253 Jun 1998 EP
0845265 Jun 1998 EP
0860210 Aug 1998 EP
0916428 May 1999 EP
0965355 Dec 1999 EP
0970751 Jan 2000 EP
1003478 May 2000 EP
1017469 Jul 2000 EP
1025923 Aug 2000 EP
1068906 Jan 2001 EP
1075875 Feb 2001 EP
1092447 Apr 2001 EP
1157689 Nov 2001 EP
1211628 Jun 2002 EP
1245244 Oct 2002 EP
1312418 May 2003 EP
1375385 Jan 2004 EP
1535643 Jun 2005 EP
1595564 Nov 2005 EP
1595822 Nov 2005 EP
1521609 Dec 2005 EP
1726324 Nov 2006 EP
1736193 Dec 2006 EP
1795221 Jun 2007 EP
1813548 Aug 2007 EP
2135632 Dec 2009 EP
2262348 Nov 2006 ES
2505688 Nov 1982 FR
2604363 Apr 1988 FR
2673608 Sep 1992 FR
2756502 Jun 1998 FR
1524431 Sep 1978 GB
2081396 Feb 1982 GB
2101020 Jan 1983 GB
2279273 Jan 1995 GB
2291135 Jan 1996 GB
2332372 Jun 1999 GB
2333129 Jul 1999 GB
2347870 Sep 2000 GB
2355252 Apr 2001 GB
2398253 Aug 2004 GB
0700839.4 Jan 2007 GB
S5684246 Jul 1981 JP
H01288265 Nov 1989 JP
H0228121 Jan 1990 JP
H057246 Feb 1993 JP
H0553470 Mar 1993 JP
H06312019 Nov 1994 JP
H07118164 May 1995 JP
H07118166 May 1995 JP
07323086 Dec 1995 JP
H08277226 Oct 1996 JP
H092442 Jan 1997 JP
H0977073 Mar 1997 JP
H09315953 Dec 1997 JP
2001518428 Oct 2001 JP
2001346878 Dec 2001 JP
2002504411 Feb 2002 JP
2002235940 Aug 2002 JP
2003511212 Mar 2003 JP
2003299717 Oct 2003 JP
2004502502 Jan 2004 JP
2004097617 Apr 2004 JP
2005511210 Apr 2005 JP
2005144459 Jun 2005 JP
2007517529 Jul 2007 JP
2007245144 Sep 2007 JP
2007534379 Nov 2007 JP
2008119489 May 2008 JP
2008541808 Nov 2008 JP
2010526620 Aug 2010 JP
2010540371 Dec 2010 JP
198100674 Mar 1981 WO
198200785 Mar 1982 WO
198300288 Feb 1983 WO
198303054 Sep 1983 WO
198605419 Sep 1986 WO
198706137 Oct 1987 WO
198803419 May 1988 WO
198900889 Feb 1989 WO
198900947 Feb 1989 WO
198902279 Mar 1989 WO
198903672 May 1989 WO
198903673 May 1989 WO
198905139 Jun 1989 WO
199009780 Sep 1990 WO
199009781 Sep 1990 WO
1991014468 Oct 1991 WO
199206704 Apr 1992 WO
199217231 Oct 1992 WO
199221332 Dec 1992 WO
199222286 Dec 1992 WO
1993013737 Jul 1993 WO
199325321 Dec 1993 WO
1993024164 Dec 1993 WO
1994007607 Apr 1994 WO
199417822 Aug 1994 WO
199425371 Nov 1994 WO
9427653 Dec 1994 WO
199503034 Feb 1995 WO
1995032015 Nov 1995 WO
9600050 Jan 1996 WO
1996006011 Feb 1996 WO
9606581 Mar 1996 WO
199623522 Aug 1996 WO
199701329 Jan 1997 WO
199706813 Feb 1997 WO
199706842 Feb 1997 WO
199712683 Apr 1997 WO
1997012687 Apr 1997 WO
199720590 Jun 1997 WO
199723208 Jul 1997 WO
9727804 Aug 1997 WO
199735562 Oct 1997 WO
199741833 Nov 1997 WO
1998012511 Mar 1998 WO
199827959 Jul 1998 WO
199831346 Jul 1998 WO
199839043 Sep 1998 WO
1999001227 Jan 1999 WO
1999007340 Feb 1999 WO
1999011563 Mar 1999 WO
1999016530 Apr 1999 WO
1999043571 Sep 1999 WO
199962495 Dec 1999 WO
199965464 Dec 1999 WO
200001612 Jan 2000 WO
200023037 Apr 2000 WO
2000023065 Apr 2000 WO
200027543 May 2000 WO
200037336 Jun 2000 WO
2000033965 Jun 2000 WO
200049988 Aug 2000 WO
200064779 Nov 2000 WO
200113885 Mar 2001 WO
200128489 Apr 2001 WO
2001064182 Sep 2001 WO
200187392 Nov 2001 WO
2001085097 Nov 2001 WO
200197888 Dec 2001 WO
200198175 Dec 2001 WO
200198176 Dec 2001 WO
200204054 Jan 2002 WO
200205879 Jan 2002 WO
200217988 Mar 2002 WO
200232899 Apr 2002 WO
2002034411 May 2002 WO
2002070141 Sep 2002 WO
2002089887 Nov 2002 WO
2003002045 Jan 2003 WO
2003014832 Feb 2003 WO
2003020253 Mar 2003 WO
2003022332 Mar 2003 WO
2003035030 May 2003 WO
2003037159 May 2003 WO
2003037259 May 2003 WO
2003049786 Jun 2003 WO
2003050031 Jun 2003 WO
2003053350 Jul 2003 WO
2003057593 Jul 2003 WO
2003059547 Jul 2003 WO
2003068299 Aug 2003 WO
2003087097 Oct 2003 WO
2003097139 Nov 2003 WO
2004019985 Mar 2004 WO
2004022052 Mar 2004 WO
2004022132 Mar 2004 WO
2004022244 Mar 2004 WO
2004024157 Mar 2004 WO
200433954 Apr 2004 WO
2004062813 Jul 2004 WO
2004078236 Sep 2004 WO
2004089551 Oct 2004 WO
2004091704 Oct 2004 WO
2004098689 Nov 2004 WO
2004098795 Nov 2004 WO
2005000476 Jan 2005 WO
2005004844 Jan 2005 WO
2005014175 Feb 2005 WO
2005020953 Mar 2005 WO
2005030211 Apr 2005 WO
2005055976 Jun 2005 WO
2005077445 Aug 2005 WO
200507997 Sep 2005 WO
2005080001 Sep 2005 WO
2005080002 Sep 2005 WO
2005087299 Sep 2005 WO
2005107837 Nov 2005 WO
2005109948 Nov 2005 WO
2005112892 Dec 2005 WO
2005112996 Dec 2005 WO
2005113007 Dec 2005 WO
2006011638 Feb 2006 WO
2006018392 Feb 2006 WO
2006027595 Mar 2006 WO
2006037636 Apr 2006 WO
2006037948 Apr 2006 WO
2006042297 Apr 2006 WO
2006045813 May 2006 WO
2006110080 Oct 2006 WO
2006125577 Nov 2006 WO
2006126014 Nov 2006 WO
2007011475 Jan 2007 WO
2007022898 Mar 2007 WO
2007030162 Mar 2007 WO
2007049239 May 2007 WO
2007060104 May 2007 WO
2007060105 May 2007 WO
2007060106 May 2007 WO
2007060107 May 2007 WO
2007060108 May 2007 WO
2007062721 Jun 2007 WO
2007090822 Aug 2007 WO
2007101557 Sep 2007 WO
2007128381 Nov 2007 WO
2007134965 Nov 2007 WO
2007134966 Nov 2007 WO
2007134967 Nov 2007 WO
2007134968 Nov 2007 WO
2007141201 Dec 2007 WO
2007141203 Dec 2007 WO
2008023017 Feb 2008 WO
2008047035 Apr 2008 WO
2008077623 Jul 2008 WO
2008124666 Oct 2008 WO
2008138936 Nov 2008 WO
2008146025 Dec 2008 WO
2009047021 Apr 2009 WO
2009047173 Apr 2009 WO
2009050978 Apr 2009 WO
2009090245 Jul 2009 WO
2009103510 Aug 2009 WO
2009115200 Sep 2009 WO
2010005946 Jan 2010 WO
2010006870 Jan 2010 WO
2010094305 Aug 2010 WO
2010094413 Aug 2010 WO
2010112358 Oct 2010 WO
2010133294 Nov 2010 WO
2010149280 Dec 2010 WO
2011006711 Jan 2011 WO
2011064160 Jun 2011 WO
2011064163 Jun 2011 WO
2011064164 Jun 2011 WO
2011131779 Oct 2011 WO
2011154295 Dec 2011 WO
2011160932 Dec 2011 WO
2012130757 Oct 2012 WO
2012159914 Nov 2012 WO
2012160047 Nov 2012 WO
2012160052 Nov 2012 WO
2012161685 Nov 2012 WO
2012162305 Nov 2012 WO
2013017640 Feb 2013 WO
2013110601 Aug 2013 WO
2013152861 Oct 2013 WO
2013152894 Oct 2013 WO
2014111370 Jul 2014 WO
2015018901 Feb 2015 WO
2015018903 Feb 2015 WO
2015018904 Feb 2015 WO
2015169431 Nov 2015 WO
2015169732 Nov 2015 WO
199901520 Dec 1999 ZA
Non-Patent Literature Citations (50)
Entry
International Search Report for PCT/EP2008/011112 dated Sep. 3, 2009.
“Activate”. Collins English Dictionary, London: Collins, 2000, 2 pages. [Retrieved at http://search.credoreference.com/content/entry/hcengdict/activate/0 on Jun. 12, 2014].
“Lung Cancer”. Merck Manual Home Edition, pp. 1-7. [Accessed at www.merck.com/mmhe/print/sec04/ch057/ch057a.html, on Jul. 28, 2010].
Abstract in English for DE19902844, 1999.
Abstract in English for DE4117078, 1992.
Abstract in English for EP0354507, 1990.
Abstract in English for FR2756502, 1998.
Abstract in English for JPS5684246, 1979.
Abstract in English for WO2009050978, 2009.
Abstract in English of DE10007591, 2000.
Abstract in English of DE202006017793, 2007.
Abstract in English of FR2604363, Sep. 30, 1986.
Abstract in English of JPH0553470, 1993.
Abstract in English of JPH057246, 1993.
Abstract in English of JPH07118164, 1995.
Abstract in English of JPH07118166, 1995.
Abstract in English of JPH08277226,1996.
Abstract in English of JPH092442, 1997.
Abstract in English of JPH09315953, 1997.
Abstract in English of JPH0977073, 1997.
Abstract in English of WO199706813, 1997.
Abstract in English of WO199839043, 1998.
Abstract in English of WO2002070141, 2002.
Ackermann et al.; Quantitative Online Detection of Low-Concentrated Drugs via a SERS Microfluidic System; ChemPhysChem; 2007; vol. 8; No. 18; pp. 2665-2670.
Beasley R et al: “Preservatives in Nebulizer solutions: Risks without Benefit” Pharmacotherapy, Boston, US, Bd. 18, Nr. 1, Jan. 1998.
Beasley R et al: “Preservatives in Nebulizer solutions: Risks without Benefit” Pharmacotherapy, Boston, US, Bd. 18, Nr. 1, Jan. 1998, pp. 130-139.
Bocci et al., “Pulmonary catabolism of interferons: alveolar absorption of 125l-labeled human interferon alpha is accompanied by partial loss of biological activity”. Antiviral Research, vol. 4, 1984, pp. 211-220.
Chen, F-K et al., “A study of forming pressure in the tube-hydroforming process”. Journal of Materials Processing Technology, 192-193, 2007, p. 404-409.
China Suppliers, Shanghai Lite Chemical Technology Co., Ltd. Product details on polyvinylpyrrolidones. Obtained online by the USPTO examiner on Apr. 24, 2011.
Cras et al., “Comparison of chemical cleaning methods of glass in preparation for silanization”. Biosensors & Bioelectronics, vol. 14, 1999, pp. 683-688.
Diamond et al., “Substance P Fails to Mimic Vagally Mediated Nonadrenergic Bronchodilation”. Peptides, vol. 3, 1982, pp. 27-29.
Elwenspoek et al., “Silicon Micromachining”, Chapter 3, Mechanical Microsensors, Springer-Verlag Berlin Heidelberg, 2001, 4 pages.
English Language Abstract of EP1068906, 2001.
Fuchs et al., “Neopterin, biochemistry and clinical use as a marker for cellular immune reactions”. International Archives of Allergy and Immunology, vol. 101, No. 1, 1993, pp. 1-6, Abstract 1p.
Han et al.; Surface activation of thin silicon oxides by wet cleaning and silanization; Thin Solid Films; 2006; vol. 510; No. 1-2; pp. 175-180.
Henkel et al.; Chip modules for generation and manipulation of fluid segments for micro serial flow processes; Chemical Engineering Journal; 2004; vol. 101; pp. 439-445.
Hoffmann et al., “Mixed self-assembled monolayers (SAMs) consisting of methoxy-tri(ethylene glycol)-terminated and alkyl-terminated dimethylchlorosilanes control the non-specific adsorption of proteins at oxidic surfaces”. Journal of Colloid and Interface Science, vol. 295, 2006, pp. 427-435.
Husseini et al., “Alkyl Monolayers on Silica Surfaces Prepared Using Neat, Heated Dimethylmonochlorosilanes with Low Vapor Pressures”. Langmuir, vol. 19, 2003, pp. 5169-5171.
IP et al., “Stability of Recombinant Consensus Interferon to Air-Jet and Ultrasonic Nebulization”. Journal of Pharmaceutical Sciences, vol. 84, No. 10, Oct. 1995, pp. 1210-1214.
Jendle et al., “Intrapulmonary administration of insulin to healthy volunteers”. Journal of Internal Medicine, vol. 240, 1996, pp. 93-98.
JP2005144459—English language abstract only.
Kutchoukov et al., “Fabrication of nanofluidic devices using glass-to-glass anodic bonding” Sensors and Actuators A, vol. 114, 2004, pp. 521-527.
Lougheed et al., “Insulin Aggregation in Artificial Delivery Systems”. Diabetologia, vol. 19, 1980, pp. 1-9.
Mandal et al., “Cytophobic surface modification of microfluidic arrays for in situ parallel peptide synthesis and cell adhesion assays”. Biotechnology Progress, vol. 23, No. 4, 2007, pp. 972-978 (Author Manuscript Available in PMC, Sep. 21, 2009, 19 pages).
Niven et al., “Some Factors Associated with the Ultrasonic Nebulization of Proteins”. Pharmaceutical Research, vol. 12, No. 1, 1995, pp. 53-59.
Remington Pharmacy, Editor Alfonso R. Gennaro. 19th ed., Spanish Secondary Edition: Panamericana, Spain, 1995, Sciarra, J. J., “Aerosols”, pp. 2560-2582. The English translation is from the 1995 English Primary Edition, Sciarra, J. J., Chapter 95, R97-1185.
Trasch et al., “Performance data of refloquant Glucose in the Evaluation of Reflotron”. Clinical Chemistry, vol. 30, 1984, p. 969.
Wall et al., “High levels of exopeptidase activity are present in rat and canine bronchoalveolar lavage fluid”. International Journal of Pharmaceutics, vol. 97, Issue 1-3, pp. 171-181, 1993, Abstract pp. 1-2.
Wang et al.; Self-Assembled Silane Monolayers: Fabrication with Nanoscale Uniformity; Langmuir; 2005; vol. 21; No. 5; pp. 1848-1857.
Abstract in English for JP2002-235940, 2001.
Related Publications (1)
Number Date Country
20110277753 A1 Nov 2011 US